Post-finasteride syndrome - a true clinical entity?

Area of Science:

• Endocrinology and Urology
• Neuroscience
• Dermatology

Background:

• Finasteride, used for hair loss and prostate issues, has been linked to persistent adverse effects post-discontinuation, termed Post-Finasteride Syndrome (PFS).
• Clinical manifestations of PFS are diverse, encompassing sexual dysfunction, neuropsychiatric symptoms, and physical changes, complicating diagnosis and management.
• The existence and recognition of PFS remain debated within the medical community, highlighting a need for further scientific inquiry.

Purpose of the Study:

• To critically review the evidence, clinical manifestations, and potential mechanisms of Post-Finasteride Syndrome (PFS).
• To address the controversies surrounding PFS and emphasize the importance of patient education and risk assessment.
• To advocate for a multidisciplinary approach in understanding, diagnosing, and managing PFS.

Main Methods:

• Systematic literature review and critical analysis of existing studies on finasteride's persistent adverse effects.
• Evaluation of reported clinical symptoms, neurobiological alterations, and genetic predispositions associated with PFS.
• Discussion of diagnostic challenges, management strategies, and the current state of medical recognition.

Main Results:

• Men using finasteride may develop a range of persistent physical and psychological symptoms indicative of PFS.
• Potential mechanisms involve neurobiological alterations and genetic factors, though evidence is still developing.
• Contrasting data exists, underscoring the complexity and contentious nature of PFS.

Conclusions:

• Post-Finasteride Syndrome presents with significant, non-neglectable symptoms requiring thorough investigation.
• Enhanced patient education and risk assessment are crucial before prescribing finasteride.
• A multidisciplinary approach involving research, policy, and patient advocacy is essential for advancing the understanding and management of PFS.